Skip to main content
. 2022 Sep 20;82(9):13855–13880. doi: 10.1007/s11042-022-13843-7

Table 2.

Splitting of the dataset for training, testing, and validation

Data Splitting COVID-19 Pneumothorax Pneumonia Lung Cancer Tuberculosis Normal Total
Training 1670 8400 2707 3500 2940 2065 21,282
Validation 467 2400 773 1000 840 589 6069
Testing 234 1200 387 500 420 295 3036
Total 2371 12,000 3867 5000 4200 2949 30,387